Viatris Promises Clarity And Certainty On $9bn Transformation Plans

As Company Sticks With 2022 FY Guidance Following Q1 Financials

 
• By Dean Rudge
  
Questions_Three
Viatris says it is aware of concerns over clarity • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business